Venus Medtech preps Hong Kong listing

By Jonathan Breen
11 Nov 2019

Chinese biotechnological company Venus Medtech (Hangzhou) is set to launch its Hong Kong IPO, having lined up an international syndicate to run the deal.

The issuer filed post-listing hearing IPO documents on Monday after getting the go-ahead from the Hong Kong Stock Exchange to list. It has appointed CICC, China Merchant Securities, Credit Suisse and Goldman Sachs as joint sponsors of the transaction.

Unlike many biotech firms that have listed in Hong ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial